Safety and clinical activity of atezolizumab plus erlotinib in patients with non-small-cell lung cancer

  1. Rudin, C.M.
  2. Cervantes, A.
  3. Dowlati, A.
  4. Besse, B.
  5. Ma, B.
  6. Costa, D.B.
  7. Schmid, P.
  8. Heist, R.
  9. Villaflor, V.M.
  10. Spahn, J.
  11. Li, S.
  12. Cha, E.
  13. Riely, G.J.
  14. Gettinger, S.
Journal:
ESMO Open

ISSN: 2059-7029

Year of publication: 2023

Volume: 8

Issue: 2

Type: Article

DOI: 10.1016/J.ESMOOP.2023.101160 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus